Abstract
Activated toll-like receptor (TLR) signaling has been well investigated in major depressive disorder (MDD). We previously reported that TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 play important roles in regulating the toll-like receptor 4 (TLR4) signaling pathway and may serve as novel targets in the pathogenesis of MDD. Recently, aberrant histone modification has been implicated in several psychiatric disorders, including schizophrenia and mood disorder; the most thoroughly studied modification is histone 3 lysine 4 tri-methylation (H3K4me3). In this work, we aimed to explore H3K4me3 differences in the promotors of genes encoding the abovementioned factors in patients with MDD, and whether they were altered after antidepressant treatment. A total of 30 MDD patients and 28 healthy controls were recruited. Peripheral blood mononuclear cells (PBMCs) were collected. The levels of H3K4me3 in the promoters of TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 were measured through chromatin immunoprecipitation (ChIP) followed by DNA methylation assay. Analysis of covariance was used to evaluate between-group differences after adjusting for age, sex, BMI, and smoking. In comparison with healthy controls, patients with MDD showed significantly lower H3K4me3 levels in the promoters of TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 in PBMCs. These levels were not significantly altered after completion of a 4-week antidepressant treatment. To explore the association between depression severity and H3K4me3 levels, a multiple linear regression model was generated. The results revealed that levels of H3K4me3 in the TNIP2 promoters a negative correlation with the 17-item Hamilton Depression Rating Scale (HAND-17) score, whereas that of TLR4 had a positive correlation with this score. The present results suggest that decreased H3K4me3 levels in the promoters of the genes encoding TNFAIP3, TLR4, miR-146a, miR-155, and TNIP2 are involved in psychopathology of major depressive disorder.
Similar content being viewed by others
Data Availability
Medical information for these participants is protected, so only processed de-identified data will be made available upon receipt of reasonable request to the corresponding author.
References
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017). Lancet 390(10100):1211–1259. https://doi.org/10.1016/s0140-6736(17)32154-2
Sun H, Kennedy PJ, Nestler EJ (2013) Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 38(1):124–137. https://doi.org/10.1038/npp.2012.73
Toraño EG, García MG, Fernández-Morera JL, Niño-García P, Fernández AF (2016) The impact of external factors on the epigenome in utero and over lifetime. Biomed Res Int 2016:2568635
Mourtzi N, Sertedaki A, Charmandari E (2021) Glucocorticoid signaling and epigenetic alterations in stress-related disorders. Int J Mol Sci 22(11):5964. https://doi.org/10.3390/ijms22115964
Palma-Gudiel H, Cordova-Palomera A, Leza JC, Fananas L (2015) Glucocorticoid receptor gene (NR3C1) methylation processes as mediators of early adversity in stress-related disorders causality: A critical review. Neurosci Biobehav Rev 55:520–535. https://doi.org/10.1016/j.neubiorev.2015.05.016
Labonté B, Azoulay N, Yerko V, Turecki G, Brunet A (2014) Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder. Transl Psychiatry 4(3):e368. https://doi.org/10.1038/tp.2014.3
Yehuda R, Flory JD, Bierer LM, Henn-Haase C, Lehrner A, Desarnaud F, Makotkine I, Daskalakis NP et al (2015) Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry 77(4):356–364. https://doi.org/10.1016/j.biopsych.2014.02.006
Peter CJ, Akbarian S (2011) Balancing histone methylation activities in psychiatric disorders. Trends Mol Med 17(7):372–379. https://doi.org/10.1016/j.molmed.2011.02.003
Saavedra K, Molina-Márquez AM, Saavedra N, Zambrano T, Salazar LA (2016) Epigenetic modifications of major depressive disorder. Int J Mol Sci 17(8):1279. https://doi.org/10.3390/ijms17081279
Turner BM (2005) Reading signals on the nucleosome with a new nomenclature for modified histones. Nat Struct Mol Biol 12(2):110–112. https://doi.org/10.1038/nsmb0205-110
Penner-Goeke S, Binder EB (2019) Epigenetics and depression. Dialogues Clin Neurosci 21(4):397–405. https://doi.org/10.31887/DCNS.2019.21.4/ebinder
Deussing JM, Jakovcevski M (2017) Histone Modifications in Major Depressive Disorder and Related Rodent Models. Adv Exp Med Biol 978:169–183. https://doi.org/10.1007/978-3-319-53889-1_9
Collins BE, Greer CB, Coleman BC, Sweatt JD (2019) Histone H3 lysine K4 methylation and its role in learning and memory. Epigenetics Chromatin 12(1):7. https://doi.org/10.1186/s13072-018-0251-8
Shen E, Shulha H, Weng Z, Akbarian S (2014) Regulation of histone H3K4 methylation in brain development and disease. Philos Trans R Soc Lond B Biol Sci 369(1652):20130514. https://doi.org/10.1098/rstb.2013.0514
Kim JH, Lee JH, Lee IS, Lee SB, Cho KS (2017) Histone lysine methylation and neurodevelopmental disorders. Int J Mol Sci 18(7):1404. https://doi.org/10.3390/ijms18071404
Nesbit N, Wallace R, Harihar S, Zhou M, Jung JY, Silberstein M, Lee PH (2021) Genomewide alteration of histone H3K4 methylation underlies genetic vulnerability to psychopathology. J Genet 100:44
Hyun K, Jeon J, Park K, Kim J (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49(4):e324. https://doi.org/10.1038/emm.2017.11
Hung YY, Lin CC, Kang HY, Huang TL (2017) TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder. Brain Behav Immun 59:265–272. https://doi.org/10.1016/j.bbi.2016.09.014
Chiang TI, Hung YY, Wu MK, Huang YL, Kang HY (2021) TNIP2 mediates GRbeta-promoted inflammation and is associated with severity of major depressive disorder. Brain Behav Immun 95:454–461. https://doi.org/10.1016/j.bbi.2021.04.021
Hung YY, Wu MK, Tsai MC, Huang YL, Kang HY (2019) Aberrant expression of intracellular let-7e, miR-146a, and miR-155 correlates with severity of depression in patients with major depressive disorder and is ameliorated after antidepressant treatment. Cells 8(7):647. https://doi.org/10.3390/cells8070647
Hung YY, Chou CK, Yang YC, Fu HC, Loh EW, Kang HY (2021) Exosomal let-7e, miR-21–5p, miR-145, miR-146a and miR-155 in predicting antidepressants response in patients with major depressive disorder. Biomedicines 9(10):1428. https://doi.org/10.3390/biomedicines9101428
Hung YY, Kang HY, Huang KW, Huang TL (2014) Association between toll-like receptors expression and major depressive disorder. Psychiatry Res 220(1–2):283–286. https://doi.org/10.1016/j.psychres.2014.07.074
Zhao H, Wang L, Luo H, Li QZ, Zuo X (2017) TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus. Rheumatology (Oxford) 56(5):835–843. https://doi.org/10.1093/rheumatology/kew508
Daems C, Sékulic M, Vulsteke V, van Loo G, D’Hooge R, Callaerts-Végh Z (2019) Callaerts P A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus. Brain Behav Immun Health. 14(2):100018. https://doi.org/10.1016/j.bbih.2019.100018
Gong H, Sheng X, Xue J, Zhu D (2019) Expression and role of TNIP2 in multiple organ dysfunction syndrome following severe trauma. Mol Med Rep 19(4):2906–2912. https://doi.org/10.3892/mmr.2019.9893
Xie H, Yang M, Zhang B, Liu M, Han S (2017) Protective Role of TNIP2 in Myocardial Injury Induced by Acute Pancreatitis and Its Mechanism. Med Sci Monit 23:5650–5656. https://doi.org/10.12659/msm.904398
Yan Z, Chen Y, Zhang X, Hua L, Huang L (2021) Neuroprotective Function of TNFAIP3 Interacting Protein 2 Against Oxygen and Glucose Deprivation/Reoxygenation-Induced Injury in Hippocampal Neuronal HT22 Cells Through Regulation of the TLR4/MyD88/NF-kappaB Pathway. Neuropsychiatr Dis Treat 17:2219–2227. https://doi.org/10.2147/NDT.S308360
Webb LV, Ventura S, Ley SC (2019) ABIN-2, of the TPL-2 Signaling Complex, Modulates Mammalian Inflammation. Trends Immunol 40(9):799–808. https://doi.org/10.1016/j.it.2019.07.001
Xia M, Liu J, Wu X, Liu S, Li G, Han C, Song L, Li Z et al (2013) Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39(3):470–481. https://doi.org/10.1016/j.immuni.2013.08.016
Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ, Radulovic J, Churchill GA et al (2012) Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry 17(1):49–61. https://doi.org/10.1038/mp.2010.119
Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Tréziny C, Verrier L, Loundou A, Baumstarck-Barrau K et al (2012) Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry 2(11):e185. https://doi.org/10.1038/tp.2012.112
Wang X, Zhu K, Li S, Liao Y, Du R, Zhang X, Shu HB, Guo AY et al (2012) MLL1, a H3K4 methyltransferase, regulates the TNFα-stimulated activation of genes downstream of NF-κB. J Cell Sci 125(Pt 17):4058–4066. https://doi.org/10.1242/jcs.103531
Carson WFT, Cavassani KA, Soares EM, Hirai S, Kittan NA, Schaller MA, Scola MM, Joshi A et al (2017) The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages. J Immunol 199(5):1865–1874. https://doi.org/10.4049/jimmunol.1601272
Jakovcevski M, Ruan H, Shen EY, Dincer A, Javidfar B, Ma Q, Peter CJ, Cheung I et al (2015) Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory. J Neurosci 35(13):5097–5108. https://doi.org/10.1523/jneurosci.3004-14.2015
Shen EY, Jiang Y, Javidfar B, Kassim B, Loh YE, Ma Q, Mitchell AC, Pothula V et al (2016) Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety. Neuropsychopharmacology 41(13):3103–3113. https://doi.org/10.1038/npp.2016.144
Bayraktar R, Bertilaccio MTS, Calin GA (2019) The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors. Front Immunol 10:1053. https://doi.org/10.3389/fimmu.2019.01053
Saba R, Sorensen DL, Booth SA (2014) MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response. Front Immunol 5:578. https://doi.org/10.3389/fimmu.2014.00578
Liu CP, Zhong M, Sun JX, He J, Gao Y, Qin FX (2021) miR146a reduces depressive behavior by inhibiting microglial activation. Mol Med Rep 23(6):463. https://doi.org/10.3892/mmr.2021.12102
Fan C, Li Y, Lan T, Wang W, Long Y, Yu SY (2022) Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression. Mol Ther 30(3):1300–1314. https://doi.org/10.1016/j.ymthe.2021.11.006
Yao Q, Chen Y, Zhou X (2019) The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol 51:11–17. https://doi.org/10.1016/j.cbpa.2019.01.024
Acknowledgements
We thank Ya-Ling Huang for excellent experiment support.
Funding
This study was supported by CMRPGTM0021 grants from Kaohsiung Chang Gung Memorial Hospital, Taiwan and by the 111–2314-B-182A-025 -MY3 grants from the National Science and Technology Council, Taiwan.
Author information
Authors and Affiliations
Contributions
Y.-Y.H. and S.-C.W. designed the study and enrolled patients. Y.-Y.H. and C.-C.T. and analyzed data. Y.-Y.H. and C.-C.T. wrote the manuscript. Y.-C.Y., H.-C.F., C.-K.C., H.-Y.K. consulted and supported the performance and evaluation of chromatin immunoprecipitation. All authors read and edited the manuscript, and approved the final version.
Corresponding author
Ethics declarations
Ethics Approval
Institutional Review Board approval was obtained from the hospital ethics committee (201901894A3).
Consent to Participate
All participants in this study provided informed written consent.
Consent for Publication
The authors approved the publication of article.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tseng, CC., Wang, SC., Yang, YC. et al. Aberrant Histone Modification of TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 in Major Depressive Disorder. Mol Neurobiol 60, 4753–4760 (2023). https://doi.org/10.1007/s12035-023-03374-z
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s12035-023-03374-z